Estrogen Therapy Study Expansion To Peri-Menopausal Women Suggested
Executive Summary
Clinical evaluations of estrogen hormone replacement therapies should enroll a study population that includes peri-menopausal women, FDA's Reproductive Health Drugs Advisory Committee concluded Oct. 18.